Human gene therapy - JoVE Visualize

Showing results (1201-1210 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|February 27, 1999

A novel tetracycline-inducible viral replication switchF Yao, E Eriksson

Human Gene Therapy|February 18, 1999

Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsulesC J Ross, M Ralph, P L Chang

Human Gene Therapy|April 21, 1999

Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wallA Rivard, Z Luo, H Perlman, et al.

Human Gene Therapy|April 21, 1999

Successful culture and sustainability in vivo of gene-modified human oral mucosal epitheliumH Mizuno, N Emi, A Abe, et al.

Human Gene Therapy|December 13, 2003

Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectorsR S Everett, B L Hodges, E Y Ding, et al.

Human Gene Therapy|December 13, 2003

Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cellsJohn De Vos, Claude Bagnis, Lydie Bonnafoux, et al.

Human Gene Therapy|December 13, 2003

Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion proteinYufei Shi, Ranjit S Parhar, Minjing Zou, et al.

Human Gene Therapy|December 13, 2003

Evidence that the mouse 3' kappa light chain enhancer confers position-independent transgene expression in T- and B-lineage cellsLai Xu, Kazuhide Tsuji, Howard Mostowski, et al.

Human Gene Therapy|December 13, 2003

Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposureThomas J Radosevich, Tatiana Seregina, Charles J Link

Human Gene Therapy|December 13, 2003

Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brainChris Van den Haute, Kristel Eggermont, Bart Nuttin, et al.

Pageof 413

Showing results (1201-1210 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|February 27, 1999

A novel tetracycline-inducible viral replication switchF Yao, E Eriksson

Human Gene Therapy|February 18, 1999

Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsulesC J Ross, M Ralph, P L Chang

Human Gene Therapy|April 21, 1999

Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wallA Rivard, Z Luo, H Perlman, et al.

Human Gene Therapy|April 21, 1999

Successful culture and sustainability in vivo of gene-modified human oral mucosal epitheliumH Mizuno, N Emi, A Abe, et al.

Human Gene Therapy|December 13, 2003

Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectorsR S Everett, B L Hodges, E Y Ding, et al.

Human Gene Therapy|December 13, 2003

Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cellsJohn De Vos, Claude Bagnis, Lydie Bonnafoux, et al.

Human Gene Therapy|December 13, 2003

Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion proteinYufei Shi, Ranjit S Parhar, Minjing Zou, et al.

Human Gene Therapy|December 13, 2003

Evidence that the mouse 3' kappa light chain enhancer confers position-independent transgene expression in T- and B-lineage cellsLai Xu, Kazuhide Tsuji, Howard Mostowski, et al.

Human Gene Therapy|December 13, 2003

Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposureThomas J Radosevich, Tatiana Seregina, Charles J Link

Human Gene Therapy|December 13, 2003

Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brainChris Van den Haute, Kristel Eggermont, Bart Nuttin, et al.

Pageof 413